Guo D, Xiao J, Liang J, Fan J, et al. CDK4/6 inhibition enhances oncolytic virus efficacy by potentiating tumor-selective cell killing and T cell activation in refractory glioblastoma. Cancer Res 2022 Jul 6. pii: 706877. doi: 10.1158/0008-5472.CAN-21-3656.
PMID: 35792620